Pharma Pulse 4/25/24: Meta’s AI Assistant Can’t Be Trusted, Remote Patient Monitoring Analysis Report 2024 & more
Pharmaceutical Executive
by
58m ago
The latest news for pharma industry insiders ..read more
Visit website
What Impact is AI Having on the Collection and Analysis of RWE?
Pharmaceutical Executive
by
58m ago
AI allows patients, doctors, and payers to make informed decisions based on evidence at a much faster pace ..read more
Visit website
Coya Therapeutics CEO Discusses Next Steps Amid Positive Results from Coya 302 Trial for ALS Treatment
Pharmaceutical Executive
by
15h ago
In an interview with Pharm Exec Associate Editor Don Tracy, Howard Berman, Chairman, CEO, Coya Therapeutics offers a preview on what the nexts steps are after presenting positive data on Coya 302 for the treatment of ALS ..read more
Visit website
FDA Approves Amneal’s Naloxone Hydrochloride Nasal Spray as an OTC Treatment for Opioid Overdose
Pharmaceutical Executive
by
18h ago
Company aims to provide affordable emergency treatment from overdoses of heroin, fentanyl, and prescription opioids ..read more
Visit website
Hey Pharma–Do You Know What Your Customers Really Want?
Pharmaceutical Executive
by
18h ago
..read more
Visit website
On the Same Page for the Future
Pharmaceutical Executive
by
21h ago
In this Pharmaceutical Executive video interview, Jon Hamrick, Partner, Curatio Scientia Advisors and Jon Rawlson, President & Founder, Armory Hill Advocates, speak about what kind of impact their survey's findings impact will be on the industry ..read more
Visit website
FDA Grants Accelerated Approval to Day One’s Ojemda for Relapsed or Refractory Pediatric Low-Grade Glioma
Pharmaceutical Executive
by
21h ago
Ojemda is the first systemic therapy approved by the FDA for the treatment of relapsed or refractory pediatric low-grade glioma harboring a BRAF fusion or rearrangement, or a BRAF V600 mutation ..read more
Visit website
Pharma Pulse 4/24/24: 5 Things You Should Know About Women's Health, Microsoft Makes Push Into Smaller AI Systems & more
Pharmaceutical Executive
by
1d ago
The latest news for pharma industry insiders ..read more
Visit website
Identifying Healthcare Trends from Conversation Data
Pharmaceutical Executive
by
1d ago
Healthcare customers and patients are facing more avenues to receive misinformation about drugs than ever before ..read more
Visit website
FDA Approves Novartis' Lutathera for Pediatric Patients with Gastroenteropancreatic Neuroendocrine Tumors
Pharmaceutical Executive
by
2d ago
Lutathera is the first FDA-approved treatment for younger patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors ..read more
Visit website

Follow Pharmaceutical Executive on FeedSpot

Continue with Google
Continue with Apple
OR